Vion
Navigation Links
Vion in Medical News
Vion Pharmaceuticals to Present Data on Onrigin(TM)at the ASCO(R) Annual Meeting
...AVEN, Conn., May 29 /PRNewswire-FirstCall/ -- vion PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) ...0, 2009. A copy of the poster will be available on vion Pharmaceuticals' website, www.vionpharm.com , o...2:00 p.m. on Saturday, May 30, 2009. About vion ...Vion Pharmaceuticals Reports 2009 First Quarter Results
...EW HAVEN, Conn., May 11 /PRNewswire-FirstCall/ -- vion PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) ...ilable through Thursday, May 28, 2009. About vion vion Pharmaceuticals, Inc. is committed to extending th...... HAVEN, Conn., April 23 /PRNewswire-FirstCall/ -- vion PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) ...to have an FDA decision this year." About vion Pharmaceuticals vion Pharmaceuticals, Inc. is committed to extending th...
Vion Pharmaceuticals' New Drug Application for Onrigin(TM)Accepted For Review by the FDA
... HAVEN, Conn., April 16 /PRNewswire-FirstCall/ -- vion Pharmaceuticals, Inc. (OTC Bulletin Board: VION) ...rst indication in the United States." About vion Pharmaceuticals vion Pharmaceuticals, Inc. is committed to extending th...Vion Updates Conference Call Information
...hrough Thursday, November 20, 2008. About Vion vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Laromustine (Cl...al Cancer Institute. For additional information on vion and its product development programs, visit the Co...Vion Reports 2008 Third Quarter and Nine-Month Results
...hrough Thursday, November 20, 2008. About Vion vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Laromustine (Cl...al Cancer Institute. For additional information on vion and its product development programs, visit the Co...Vion Reports 2008 Second Quarter and Six-Month Results
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced financial results for the three-... through Thursday, August 21, 2008. About Vion vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ......nc. (OTC Bulletin Board: TPIM), RXi Pharmaceuticals Corp. (Nasdaq: RXII ), vion Pharmaceuticals Inc. (Nasdaq: vion ), Neuralstem Inc. (Amex: CUR ), Amgen Inc. (Nasdaq: AMGN ), Gilead Scien...
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that data from the Phase III tri...presentation of the unblinded data. About Vion vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...
Vion Pharmaceuticals to Appeal Nasdaq Delisting
... NEW HAVEN, Conn., May 8 /PRNewswire-FirstCall/ -- vion PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that it had received a letter, d...ant the Company's request for continued listing. vion Pharmaceuticals, Inc. is committed to extending th...Vion in Medical Technology
...nducted at
various sites in France.
About Vion
vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in
clinical trials. Laromustine (Cl...al Cancer Institute. For additional information on vion and its
product development programs, visit the Co...
...s, Belgium, Switzerland and Norway. About Vion vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Laromustine (Cl...al Cancer Institute. For additional information on vion and its product development programs, visit the Co...
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that data from a previously cond...g/m2 of Cloretazine(R) (VNP40101M). About Vion vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that interim data from the pivot...gy Annual Meeting in December 2007. About Vion vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that data from two clinical tria...1, 2008. A copy of the poster will be available on vion Pharmaceuticals' website, http://www.vionpharm.co...m E354a. A copy of the poster will be available on vion Pharmaceuticals' website, http://www.vionpharm.co...
... NEW HAVEN, Conn., May 8 /PRNewswire-FirstCall/ -- vion PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced the start of an investigator-spo... as well as improve the quality of their lives." vion Pharmaceuticals, Inc. is committed to extending th...
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that the U.S. Food and Drug Admi...ewers performed a comprehensive safety analysis of vion Study CLI-037. This analysis concluded that the co...(R)) in December 2007. Conference Call Details vion will hold a conference call on Tuesday, January 8,...
...FirstCall/ -- Vion Pharmaceuticals, Inc. (Nasdaq: vion ) today announced that preliminary data from its p... poster. A copy of the poster will be available on vion Pharmaceuticals' website, http://www.vionpharm.co... be available through Monday, December 24, 2007. vion Pharmaceuticals, Inc. is committed to extending th...
...ntribution in the stem cell transplant setting." vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...al Cancer Institute. For additional information on vion and its product development programs, visit the Co...
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that an investigator-sponsored t...of Clinical Oncology Annual Meeting in June 2007. vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...
...s, Belgium, Switzerland and Norway. About Vion vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Laromustine (Cl...al Cancer Institute. For additional information on vion and its product development programs, visit the Co...
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that data from a previously cond...g/m2 of Cloretazine(R) (VNP40101M). About Vion vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that interim data from the pivot...gy Annual Meeting in December 2007. About Vion vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that data from two clinical tria...1, 2008. A copy of the poster will be available on vion Pharmaceuticals' website, http://www.vionpharm.co...m E354a. A copy of the poster will be available on vion Pharmaceuticals' website, http://www.vionpharm.co...
... NEW HAVEN, Conn., May 8 /PRNewswire-FirstCall/ -- vion PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced the start of an investigator-spo... as well as improve the quality of their lives." vion Pharmaceuticals, Inc. is committed to extending th...
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that the U.S. Food and Drug Admi...ewers performed a comprehensive safety analysis of vion Study CLI-037. This analysis concluded that the co...(R)) in December 2007. Conference Call Details vion will hold a conference call on Tuesday, January 8,...
...FirstCall/ -- Vion Pharmaceuticals, Inc. (Nasdaq: vion ) today announced that preliminary data from its p... poster. A copy of the poster will be available on vion Pharmaceuticals' website, http://www.vionpharm.co... be available through Monday, December 24, 2007. vion Pharmaceuticals, Inc. is committed to extending th...
...ntribution in the stem cell transplant setting." vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...al Cancer Institute. For additional information on vion and its product development programs, visit the Co...
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that an investigator-sponsored t...of Clinical Oncology Annual Meeting in June 2007. vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...
Vion in Biological Technology
Vion Pharmaceuticals Submits New Drug Application for Onrigin(TM)
...W HAVEN, Conn., Feb. 17 /PRNewswire-FirstCall/ -- vion PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) ...d, "This NDA filing is a significant milestone for vion and for the Onrigin clinical development program. ...tions are needed for this population. About vion ...Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting
...EW HAVEN, Conn., Dec. 4 /PRNewswire-FirstCall/ -- vion PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) ...an Francisco from December 6-9, 2008. vion Poster Presentation The Company announc... New Trade Name for Laromustine vion will introduce Onrigin(TM) as the new trade name f...Vion Reports 2008 First Quarter Results
... NEW HAVEN, Conn., May 5 /PRNewswire-FirstCall/ -- vion PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced financial results for the three-...ained herein are provided on a post-split basis. vion Pharmaceuticals, Inc. is committed to extending th...Vion Pharmaceuticals Files Plan With Nasdaq
...FirstCall/ -- Vion Pharmaceuticals, Inc. (Nasdaq: vion ) today announced that it had filed a plan to achi...cision to a Nasdaq Listing Qualifications Panel. vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...Vion Reports 2007 Fourth Quarter and Year-End Results
...ained herein are provided on a post-split basis. vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...nce of unanticipated events. COMPANY CONTACT: vion Pharmaceuticals, Inc. Alan Kess......ill be available through Tuesday, April 1, 2008. vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...al Cancer Institute. For additional information on vion and its product development programs, visit the Co...
Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that the Company would implement...nesday, February 20, 2008. On a pre-split basis, vion Pharmaceuticals has 81,017,569 shares outstanding ...ult of the reverse stock split, every 10 shares of vion Common Stock will be combined into one share of...Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that the Company had paid intere... interest was paid in lieu of fractional shares. vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...Vion Pharmaceuticals Holds Special Meeting of Stockholders
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) announced that a Special Meeting of Stockholders... compliance with Nasdaq's listing requirements." vion Pharmaceuticals, Inc. is committed to extending th...nd commercializing innovative cancer therapeutics. vion has two agents in clinical trials. Cloretazine(R) ...Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
...FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: vion ) today announced that William Hahne, M.D. has joi...e are extremely pleased to have Bill Hahne joining vion in medical affairs. He has a wealth of experience ...ersity Affiliated Hospitals in Atlanta, Georgia. vion Pharmaceuticals, Inc. is committed to extending th...Other TagsDraftSwansOther Contentsroseolacuffcuffcuffrotatorrotatorrotatorroundwormsroundwormsrubellarubellarubellarubellacementcementcementrubberrubberrubberrubberrubberrubberrubeola
(Date:11/27/2009)...al, economic burdens, study predicts , ,... people with diabetes in the United States is expe... predicts. , That would bring the total by 2034... from 23.7 million today. , , At the same time, ...ple, the study also warns, rising from an estimate...
(Date:11/27/2009)...acturers who use medical load cells at the heart o... bringing in technology partner Flintec early in t...e medical manufacturers are calling in Flintec loa...cts, ensuring that progress will not be constraine...ated technology. , (PRWEB...
(Date:11/26/2009)...icans living with diabetes will nearly double, inc...in 2034. Over the same period, spending on diabete...$336 billion, even with no increase in the prevale...y of Chicago report in the December issue of Diab...covered by Medicare will rise from 8.2 million to ...
(Date:11/26/2009)...from the North Pole, Textsanta.net lets parents si... North Pole, AK (PRWEB) --... at the North Pole Santa Claus has added SMS text ... informed of his Christmas progress at the North P...t have identified a large and growing percentage o...
(Date:11/26/2009)...s, P.A. is offering free nationwide confidential c...trol pills who have suffered a Deep Vein Thrombosi...or other related cardiac issues or had their Gallb...856-6405 or go to the firm’s website at htt...evaluation form. , (PRWEB...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3[0] Diabetes Cases Expected to Double in 25 Years[0] Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells[0] Diabetes cases to double and costs to triple by 2034[1] Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes[0] Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills
(Date:11/26/2009)... What are the bare essentials of life, the indispe... can survive on its own? Can we describe the molec...re organism functions as a system? These are just ...ship between the European Molecular Biology Labora... de Regulacio Genmica (CRG) in Barcelona, Spain, s...
(Date:11/25/2009)...lice officers and ambulance workers faced a terrif...ex. They battled to save people from the collapsin...es and evacuated as many people as they could in a... And making their jobs even harder was the problem...eir relatives jammed mobile networks with calls an...
(Date:11/25/2009)... just as vital to your health as what you eat, fou...l Studies. Their experiments in mice revealed that... in the liverthe body,s metabolic clearinghouseis ...dy,s circadian clock as conventional wisdom had it... a large number of genes completely independent of...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3Doctor Diabetic Supply Inc Acquires Diabetes Source Rx 49107 1Doctor Diabetic Supply Inc Acquires Diabetes Source Rx 49107 2Matrixx Initiatives Inc Received a Warning Letter From the Food and Drug Administration 49103 1Matrixx Initiatives Inc Received a Warning Letter From the Food and Drug Administration 49103 2Matrixx Initiatives Inc Received a Warning Letter From the Food and Drug Administration 49103 3Strides Made in Hemophilia Research 49100 1Strides Made in Hemophilia Research 49100 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |